Cargando…

SUN-344 SDHB Immunostaining: Still an Indispensable Tool in Characterising Pheochromocytoma and Paraganglioma

Background: SDHB immunostaining can be used to functionally characterize SDH status in PCC and PGL. Assessing SDHB expression on tumors is inexpensive and can be used as an alternative to genetic testing. More importantly, assessment of SDHB expression can be of value in interpreting Variant of Unkn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Velusamy, Anand, Moonim, Mufaddal, Hubbard, Johnathan, McGowan, Barbara, Powrie, Jake, Izatt, Louise, Obholzer, Rupert, Jacques, Audrey, Breen, Louise, Carroll, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Adrenal
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552923/ http://dx.doi.org/10.1210/js.2019-SUN-344

Ejemplares similares

Using Multimodal Functional Imaging in the Management of SDHx-Related Pheochromocytoma and Paraganglioma
por: White, Gemma, et al.
Publicado: (2021)

PSUN27 Largest Cohort of Cervical Spine Metastases of Pheochromocytoma/Paraganglioma in the Setting of SDHB Mutation
por: Pacak, Karel, et al.
Publicado: (2022)

Tumour detection and outcomes of surveillance screening in SDHB and SDHD pathogenic variant carriers
por: White, Gemma, et al.
Publicado: (2022)

A Multifocal Paraganglioma in an African Male Due to an Underlying SDHB Mutation
por: Siddiqui, Nida Mishraz, et al.
Publicado: (2021)

Transaminitis Evaluation Leads to the Incidental Diagnosis of Familial Paraganglioma Due to SDHB Mutation
por: Okafor, Anderson, et al.
Publicado: (2021)

Mutational Profile of Metastatic Pheochromocytoma and Paraganglioma
por: Choi, Yun Mi, et al.
Publicado: (2021)

SAT-186 Metastatic Paraganglioma Secondary to SDHB Gene Mutation: A Case Report and Review of New Therapies
por: Tetlay, Maryam, et al.
Publicado: (2020)

MON-199 Targeting Pheochromocytoma/Paraganglioma with Polyamine Inhibitors
por: Ghayee, Hans Kumar, et al.
Publicado: (2020)

MON-202 Germline SDHB Exon 1 Deletion Is Associated with Absence of (131)I-metaiodobenzylguanidine (MIBG) Uptake in Malignant Paragangliomas
por: Petenuci, Janaina, et al.
Publicado: (2020)

RF09 | PSUN29 Evidence for a Founder Effect of SDHB Exon 1 Complete Deletion in Brazilian Patients with Paraganglioma
por: Fagundes, Gustavo F, et al.
Publicado: (2022)

MON-218 Clinical and Genetic Aspects of Pediatric Pheochromocytomas and Paragangliomas
por: Petenuci, Janaina, et al.
Publicado: (2020)

MON-204 Pheochromocytoma and Paraganglioma: An Emerging Cause of Secondary Osteoporosis
por: Yokomoto-Umakoshi, Maki, et al.
Publicado: (2020)

Novel Germline SUCLG2 Mutations in Patients With Pheochromocytoma and Paraganglioma
por: Vanova, Katerina Hadrava, et al.
Publicado: (2021)

ODP032 Case Series: Prazosin in the Preoperative Management of Pheochromocytoma and Paraganglioma
por: Barreiro, Margarita, et al.
Publicado: (2022)

Germline SDHB and SDHD mutations in pheochromocytoma and paraganglioma patients
por: Huang, Yiqiang, et al.
Publicado: (2018)

Efficacy of Immunohistochemistry for SDHB in the Screening of Hereditary Pheochromocytoma–Paraganglioma
por: Choi, Hye-Ryeon, et al.
Publicado: (2021)

RF33 | PSUN03 Rates of Pheochromocytoma/Paraganglioma Screening in At-Risk Populations
por: Grigoryan, Seda, et al.
Publicado: (2022)

MON-377 Hereditary Paraganglioma Pheochromocytoma Syndrome in the Setting of End Stage Renal Disease
por: Harty, Roger
Publicado: (2019)

OR29-4 Pregnancy Outcomes in Women with Pheochromocytoma and Paraganglioma: An International Multi-Center Study
por: Bancos, Irina, et al.
Publicado: (2019)

FRI369 SDHB Hereditary Pheochromocytoma Paraganglioma Syndrome With Biochemically Silent Pheochromocytoma
por: Skariah, Annie M, et al.
Publicado: (2023)

MON-383 Sporadic Bilateral Pheochromocytoma with Renal Pelvis Paraganglioma: A Rare Coexisting Occurrence
por: Pirela, Daniela, et al.
Publicado: (2019)

OR29-6 Brown Adipose Tissue Activation in SDHx-Related Pheochromocytoma and Paraganglioma: An Ominous Sign?
por: Abdul Sater, Zahraa, et al.
Publicado: (2019)

MON-195 Genetic Analysis and Clinical Characteristics of Hereditary Paraganglioma and Pheochromocytoma Syndrome in Korean Population
por: Choi, Heewon, et al.
Publicado: (2020)

The first Dutch SDHB founder deletion in paraganglioma – pheochromocytoma patients
por: Bayley, Jean-Pierre, et al.
Publicado: (2009)

Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas
por: Sarkadi, Balazs, et al.
Publicado: (2020)

MON-385 Malignant Pheochromocytoma/Paraganglioma Syndrome during Pregnancy: Clinical Case Report, a Therapeutic Challenge
por: Sanchez, Pedro, et al.
Publicado: (2019)

MON-214 Biochemical Abnormalities in Endocrine Function Associated with Lutetium 177-DOTATATE Therapy in Metastatic Pheochromocytoma and Paraganglioma
por: Gubbi, Sriram, et al.
Publicado: (2020)

MON-196 A Single-Center Experience of Patients with Metastatic Pheochromocytoma/Paraganglioma Treated with (177)Lu-DOTATATE
por: Roslyakova, Anna, et al.
Publicado: (2020)

Changes in Clinical Presentation and Perioperative Management of Pheochromocytomas and Paragangliomas: A Four-Decade Experience in a Academic Center
por: Uslar, Thomas, et al.
Publicado: (2021)

SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis
por: Su, Tingwei, et al.
Publicado: (2023)

Predicted Succinated Dehydrogenase Subunit Variant Pathogenicity: Why Are SDHB Variants “Bad”?
por: Gruber, Lucinda, et al.
Publicado: (2021)

SDHB-Associated Paraganglioma in a Pediatric Patient and Literature Review on Hereditary Pheochromocytoma-Paraganglioma Syndromes
por: Choat, Heather, et al.
Publicado: (2014)

Pheochromocytoma in a Twelve-Year-Old Girl with SDHB-Related Hereditary Paraganglioma-Pheochromocytoma Syndrome
por: Graham, Daryl, et al.
Publicado: (2014)

Targeting NRF2-Governed Glutathione Synthesis for SDHB-Mutated Pheochromocytoma and Paraganglioma
por: Liu, Yang, et al.
Publicado: (2020)

Preoperative Amlodipine Is More Efficacious Than Prazosin in Preventing Intraoperative Haemodynamic Instability in Pheochromocytoma/Paraganglioma Patients: Interim Analysis of a Pilot Randomized Controlled Study
por: Memon, Saba Samad, et al.
Publicado: (2021)

SAT344 Takotsubo Cardiomyopathy Complicating Cholecystectomy In A Patient With Clinically Silent Pheochromocytoma
por: Huynh, Ky Buu, et al.
Publicado: (2023)

MON-924 Susceptibility Genetic Testing and Functional Imaging Modalities in the Management of Bladder Paragangliomas
por: Anandappa, Samantha, et al.
Publicado: (2020)

Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma
por: Bayley, Jean-Pierre, et al.
Publicado: (2006)

OR12-5 | LBSAT57 Long-term Follow-Up of Pheochromocytoma/Paraganglioma (PPGL) after first diagnosis: a retrospective single-center study of 173 patients
por: Krall, Christoph, et al.
Publicado: (2022)

Dutch founder SDHB exon 3 deletion in patients with pheochromocytoma-paraganglioma in South Africa
por: Gordon, Debra M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1a6dtv92rkvh3em8n343r5qah3